Patients Views & Analysis

Views & Analysis

Patients

Medicines access concept, life sciences symbols on aqua background

Approval is not access: Pilots’ real test is implementation

A medicine can be nationally recommended and still be difficult to access if local systems are not ready to identify, offer, deliver, and monitor it.

Patients

Innovation can transform NHS care, but scaling is the missin...

Innovation is already improving care across the NHS, but we are not yet consistently delivering at scale for the benefit of patients

Patients

Reshaping the future of patient-centric drug development

Strategic partnerships, robust quality systems, and manufacturing know-how will support next-generation therapies with patient-centric designs.

Patients

Longevity as the new health paradigm: The control system

Nutrition shapes the biology of ageing; lifestyle determines how that biology is expressed

Patients

12 Questions with Kim Innes

Kim Innes is General Manager of Teva UK. She has more than 30 years’ experience across the pharmaceutical industry.

Patients

Why Britain's blood tests are only as reliable as the journe...

What happens in phlebotomy has a huge impact in pathology, and the different funding streams and management means that interests are no longer aligned

Approval is not access: Pilots’ real test is implementation

Innovation can transform NHS care, but scaling is the missin...

Reshaping the future of patient-centric drug development

Longevity as the new health paradigm: The control system

12 Questions with Kim Innes

Why Britain's blood tests are only as reliable as the journe...

Novartis sets sights on new oral MS drug after phase 3 wins

Discover a new era of healthcare panel engagement: Grounded ...

Views & Analysis

Editor's Picks